Actuate Therapeutics, Inc. (ACTU)
0.3202
-0.01
(-2.08%)
USD |
NASDAQ |
Nov 06, 10:32
Actuate Therapeutics Net Income (Quarterly) : -4.867M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.867M |
| March 31, 2026 | -5.626M |
| December 31, 2025 | -4.554M |
| September 30, 2025 | -5.408M |
| June 30, 2025 | -5.949M |
| March 31, 2025 | -6.317M |
| December 31, 2024 | -6.446M |
| Date | Value |
|---|---|
| September 30, 2024 | -5.971M |
| June 30, 2024 | -6.572M |
| March 31, 2024 | -8.296M |
| December 31, 2023 | -7.612M |
| September 30, 2023 | -6.338M |
| June 30, 2023 | -5.524M |
| March 31, 2023 | -5.270M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AbbVie, Inc. | 4.207B |
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.867M |
| EPS Diluted (Quarterly) | -0.2039 |
| Enterprise Value | 3.832M |
| Earnings Yield | -278.4% |
| Normalized Earnings Yield | -278.42 |